42 HAYARKON STREET, YAVNE, L3
Reports First Quarter 2026 Financial Results and Provides Corporate Update
Results of 2026 Annual Shareholder Meeting
Reported that the contract is for the procurement of NexoBrid, establishment and maintenance of a Vendor Managed Inventory (VMI) system, design and validation of a U.S.-based manufacturing facility, and the development of a next generation formulation and additional indication for NexoBrid.
2026 Annual General Meeting of Shareholders
Material disclosure
Extraordinary General Meeting of Shareholders to Be Held on February 19, 2026
Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference
Annual and Transition Report of Foreign Private Issuers
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities of Certain Foreign Private Issuers and Certain Canadian Issuers, Offered on a Continuous Basis
No filings found
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Correspondence
Submission Upload